These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8601042)

  • 21. Selective heparinization of the extracorporeal membrane oxygenation circuit using continuous infusions of protamine and heparin in a short-term pig model.
    Dickey LA; Butler TJ; Bergmann TM; Bates ME; Null DM
    Perfusion; 1994; 9(5):327-33. PubMed ID: 7833540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of a new anticoagulant (Nafamostat Mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation--a preliminary report.
    Nagaya M; Futamura M; Kato J; Niimi N; Fukuta S
    J Pediatr Surg; 1997 Apr; 32(4):531-5. PubMed ID: 9126748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose heparin during extracorporeal membrane oxygenation treatment in adults.
    Yeo HJ; Kim DH; Jeon D; Kim YS; Cho WH
    Intensive Care Med; 2015 Nov; 41(11):2020-1. PubMed ID: 26271907
    [No Abstract]   [Full Text] [Related]  

  • 24. Extracorporeal membrane oxygenation without anticoagulation: a study using quantitative scanning electron microscopy.
    Kundu SK; Salley SO; Whittlesey GC; Klein MD
    J Lab Clin Med; 1989 Jul; 114(1):58-62. PubMed ID: 2738449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracorporeal membrane oxygenation-hemostatic complications.
    Murphy DA; Hockings LE; Andrews RK; Aubron C; Gardiner EE; Pellegrino VA; Davis AK
    Transfus Med Rev; 2015 Apr; 29(2):90-101. PubMed ID: 25595476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thrombosis-resistant heparin-coated diffusion membrane oxygenators: an experimental study].
    Tkebuchava T; von Segesser LK; Leskosek B; Pei P; Turina M
    Swiss Surg Suppl; 1996; Suppl 1():36-40. PubMed ID: 8653573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical biocompatibility study of ultra-compact durable ECMO system in chronic animal experiments for 2 weeks.
    Akiyama D; Katagiri N; Mizuno T; Tsukiya T; Takewa Y; Tatsumi E
    J Artif Organs; 2020 Dec; 23(4):335-341. PubMed ID: 32514701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation.
    Nankervis CA; Preston TJ; Dysart KC; Wilkinson WD; Chicoine LG; Welty SE; Nelin LD
    ASAIO J; 2007; 53(1):111-4. PubMed ID: 17237658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is heparin necessary for extracorporeal circulation?
    Whittlesey GC; Kundu SK; Salley SO; Nowlen TT; Klein MD
    ASAIO Trans; 1988; 34(3):823-6. PubMed ID: 3143388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The combined use of pumpless extracorporeal lung assist and continuous arteriovenous hemofiltration with citrate anticoagulation in polytrauma patients.
    Atalan HK; Gucyetmez B; Dumantepe M; Berktas M; Denizalti TB; Tarhan İA; Ozler A
    Intensive Care Med; 2015 Nov; 41(11):2024-5. PubMed ID: 26297121
    [No Abstract]   [Full Text] [Related]  

  • 31. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.
    Maul TM; Wolff EL; Kuch BA; Rosendorff A; Morell VO; Wearden PD
    Pediatr Crit Care Med; 2012 Nov; 13(6):e363-71. PubMed ID: 22940857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do we need heparin coating for extracorporeal membrane oxygenation? New concepts and controversial positions about coating surfaces of extracorporeal circuits.
    Silvetti S; Koster A; Pappalardo F
    Artif Organs; 2015 Feb; 39(2):176-9. PubMed ID: 25041628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulation therapy advisor: a decision-support system for heparin therapy during ECMO.
    Peverini RL; Sale M; Rhine WD; Fagan LM; Lenert LA
    Proc Annu Symp Comput Appl Med Care; 1992; ():567-71. PubMed ID: 1482937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival.
    Baird CW; Zurakowski D; Robinson B; Gandhi S; Burdis-Koch L; Tamblyn J; Munoz R; Fortich K; Pigula FA
    Ann Thorac Surg; 2007 Mar; 83(3):912-9; discussion 919-20. PubMed ID: 17307433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective analysis of 99 patients with the application of extracorporeal membrane oxygenation in Fuwai Hospital.
    Yuan Y; Gao G; Long C; Hei F; Li J; Liu J; Feng Z; Yu K; Zhao J; Lrou S; Hu S; Chang Q; Liu Y; Xu J; Wang X; Liu P
    ASAIO J; 2009; 55(5):474-7. PubMed ID: 19701084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Extracorporeal membrane oxygenation for severe acute respiratory and heart failure in a child with severe pneumonia].
    Xu X; Feng ZC; Hong XY; Fu S; Zhou GX; Guo WZ; Yin X
    Zhonghua Er Ke Za Zhi; 2009 Nov; 47(11):852-5. PubMed ID: 20078999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Heparin-Resistant Patients with Benefits? Maximizing Biocompatibility in Cardiopulmonary Bypass: Combining ATryn® Recombinant Antithrombin III and Carmeda® Heparin-Bonded Perfusion Circuits: A Case Series.
    Chryssos A; Stroup SJ; Pifer MM; Tawil M; Conrad CG
    J Extra Corpor Technol; 2015 Mar; 47(1):44-7. PubMed ID: 26390679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory and clinical predictors of thrombosis and hemorrhage in 29 pediatric extracorporeal membrane oxygenation nonsurvivors.
    Reed RC; Rutledge JC
    Pediatr Dev Pathol; 2010; 13(5):385-92. PubMed ID: 20085498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A reevaluation of heparin requirements for cardiopulmonary bypass.
    Cardoso PF; Yamazaki F; Keshavjee S; Schaefers HJ; Hsieh CM; Wang LS; Glynn MF; Patterson GA; Cooper JD
    J Thorac Cardiovasc Surg; 1991 Jan; 101(1):153-60. PubMed ID: 1986159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of thrombotic deposits in extracorporeal membrane oxygenators by multidetector computed tomography.
    Dornia C; Philipp A; Bauer S; Lubnow M; Müller T; Lehle K; Schmid C; Müller-Wille R; Wiggermann P; Stroszczynski C; Schreyer AG
    ASAIO J; 2014; 60(6):652-6. PubMed ID: 25158889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.